Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Carrasco

Showing results (241-250 of 271) with videos related to

Pageof 28
Sort By:
Science Translational Medicine|August 24, 2012
Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signalingKohichi Takada, Di Zhu, Gregory H Bird, et al.
Cell Reports|March 17, 2021
Excision of mutagenic replication-blocking lesions suppresses cancer but promotes cytotoxicity and lethality in nitrosamine-exposed miceJennifer E Kay, Joshua J Corrigan, Amanda L Armijo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026
Preclinical <sup>203/212</sup>Pb-DOTA-Based Pretargeted Radioimmunotherapy in Nude Mice Bearing Established Human Colorectal Cancer XenograftsBrett A Vaughn, Darren R Veach, Daniela Burnes Vargas, et al.
Microbiology Spectrum|November 28, 2023
Gastric coinfection with thiopeptide-positive <i>Cutibacterium acnes</i> decreases FOXM1 and pro-inflammatory biomarker expression in a murine model of <i>Helicobacter pylori</i>-induced gastric cancerCourtney Lunger, Zeli Shen, Hilda Holcombe, et al.
Journal of Patient-Reported Outcomes|December 23, 2019
BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis: the prospective MABOMET GEICAM studyA Barnadas, M Muñoz, M Margelí, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2018
Outcomes of single versus double hormone receptor-positive breast cancer. A GEICAM/9906 sub-studyJ L Ethier, A Ocaña, A Rodríguez Lescure, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 17, 2018
Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudyA J Templeton, Á Rodríguez-Lescure, A Ruíz, et al.
American Journal of Clinical Oncology|December 3, 2009
Is it possible to increase pCR in the neoadjuvant treatment with a dose-dense/sequential combination?: results from a phase II Trial combining epirubicin and cyclophosphamide followed by paclitaxel and gemcitabine ± trastuzumab in stage II and III breast cancer patientsAlfonso Sánchez-Muñoz, R Dueñas-García, A Jaén-Morago, et al.
Scientific Reports|December 29, 2019
Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry)Sara Lopez-Tarruella, M J Escudero, Marina Pollan, et al.
Research Square|October 16, 2023
Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunctionCorina Amor, Inés Fernández-Maestre, Saria Chowdhury, et al.
Pageof 28

Showing results (241-250 of 271) with videos related to

Sort By:
Pageof 28
Science Translational Medicine|August 24, 2012
Targeted disruption of the BCL9/β-catenin complex inhibits oncogenic Wnt signalingKohichi Takada, Di Zhu, Gregory H Bird, et al.
Cell Reports|March 17, 2021
Excision of mutagenic replication-blocking lesions suppresses cancer but promotes cytotoxicity and lethality in nitrosamine-exposed miceJennifer E Kay, Joshua J Corrigan, Amanda L Armijo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026
Preclinical <sup>203/212</sup>Pb-DOTA-Based Pretargeted Radioimmunotherapy in Nude Mice Bearing Established Human Colorectal Cancer XenograftsBrett A Vaughn, Darren R Veach, Daniela Burnes Vargas, et al.
Microbiology Spectrum|November 28, 2023
Gastric coinfection with thiopeptide-positive <i>Cutibacterium acnes</i> decreases FOXM1 and pro-inflammatory biomarker expression in a murine model of <i>Helicobacter pylori</i>-induced gastric cancerCourtney Lunger, Zeli Shen, Hilda Holcombe, et al.
Journal of Patient-Reported Outcomes|December 23, 2019
BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis: the prospective MABOMET GEICAM studyA Barnadas, M Muñoz, M Margelí, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2018
Outcomes of single versus double hormone receptor-positive breast cancer. A GEICAM/9906 sub-studyJ L Ethier, A Ocaña, A Rodríguez Lescure, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 17, 2018
Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudyA J Templeton, Á Rodríguez-Lescure, A Ruíz, et al.
American Journal of Clinical Oncology|December 3, 2009
Is it possible to increase pCR in the neoadjuvant treatment with a dose-dense/sequential combination?: results from a phase II Trial combining epirubicin and cyclophosphamide followed by paclitaxel and gemcitabine ± trastuzumab in stage II and III breast cancer patientsAlfonso Sánchez-Muñoz, R Dueñas-García, A Jaén-Morago, et al.
Scientific Reports|December 29, 2019
Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry)Sara Lopez-Tarruella, M J Escudero, Marina Pollan, et al.
Research Square|October 16, 2023
Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunctionCorina Amor, Inés Fernández-Maestre, Saria Chowdhury, et al.
Pageof 28